|
Shareholder representative
Darmstadt, Germany
Member since: Mai 2022
|
Personal Information
|
| Date of Birth: |
27 December 1966 |
| Place of Birth: |
Attendorn, Germany |
| Nationality: |
German |
Education
|
|
MSc – Master of Economics, Albert-Ludwigs-University Freiburg, Germany
MA – Master of Arts in Roman Philology, Albert-Ludwigs-University Freiburg, Germany
BA – Licence Franco-Allemande, Nouvelle Sorbonne Paris III, France
|
Career
|
| 2018 - 2020 |
Procter & Gamble (Geneva, Switzerland),
CEO Personal Healthcare Internationa |
| 1999 - 2018 |
Merck KGaA (Darmstadtand Reinbek, Germany)
- CEO & President of Merck Consumer Health division
- CEO Allergopharma GmbH & Co KG and Head of Global Business Unit Allergy
- Executive Vice President Corporate Finance
- Senior Vice President Corporate M&A and Merger Integration
- Vice President Financial Controlling Business Sector Pharmaceuticals
- Director Acquisitions Controlling
|
| 1996 - 1999 |
Hoechst AG (Frankfurt, Germany)
Senior Financial Auditor/Financial Auditor in Corporate Internal Auditing
|
| 1993 - 1995 |
Albert-Ludwigs-University (Freiburg, Germany)
Assistant Professor at Department of Roman Philology |
Membership in Supervisory Boards and Comparable Controlling Bodies
|
- Klosterfrau AG, Zürich, Board Member
- Affimed NV, Heidelberg, NASDAQ listed, Board Member + Chair Audit Committee
- Karo Pharma AB, Sweden, listed at Nasdaq Stockholm, Board Member + Audit Committee
- Röchling SE & CO KG, Mannheim, Board Member + member of Medical Board
- Schott AG, Mainz, Board Member
|
